Scancell Holdings Plc (LON:SCLP)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $6.33 and traded as low as $5.20. Scancell shares last traded at $5.37, with a volume of 23,607 shares changing hands.
The company has a market capitalization of $24.43 million and a PE ratio of -3.50. The firm’s fifty day simple moving average is GBX 6.26 and its 200 day simple moving average is GBX 6.47.
Scancell Company Profile (LON:SCLP)
Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.
Further Reading: Should I follow buy, hold and sell recommendations?
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.